Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Mississippi for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Mississippi only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Mississippi (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Laurie Douglas (NPI 1013173590)

Field	Value
Entity Type	Individual
Organization	Laurie Douglas
Address	301 S 28th Ave
City	Hattiesburg
State	MS
ZIP	39401
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	August 4, 2008

Payer Source	Total Paid
Medicare	$1.2M
Medicaid	$0

Key Findings

This provider’s billing footprint is effectively single‑payer Medicare with Total Medicare revenue of $1.2M and no Medicaid billing on file; the NPI was enumerated 2008-08-04 (~18 years ago), indicating long tenure in the Medicare program. The absence of Medicaid activity means analyses of state Medicaid competitive positioning are not applicable for this provider.

Revenue is highly concentrated: the precomputed top 3 Medicare codes by revenue account for 75.1% of this provider’s total Medicare revenue, with J9271 representing $680.4K (56.0% of Medicare revenue), J0897 representing $143.6K (11.8%), and 99213 representing $88.7K (7.3%). This concentration signals that a small set of therapies and visit types drive most of the practice’s Medicare receipts.

The service mix is characteristic of an outpatient oncology infusion practice: J9271 (pembrolizumab) and J0897 (denosumab) are the top drug revenues and multiple chemotherapy administration and infusion codes (96413, 96401, 96365, 96417, 96415) are present, while frequent E/M coding (99213) supports ongoing longitudinal office-based management. Together these codes suggest the provider administers IV immunotherapy and supportive agents onsite and provides routine follow-up visits tied to infusion care.

Competitive standing on key drugs is mixed: J9271 ranks #605 of 1841 providers nationally (67th percentile), described as a typical, unremarkable volume for this code, so the provider is not a dominant national player for pembrolizumab despite it being the largest revenue source. By contrast, J0897 ranks #1584 of 10057 providers nationally (84th percentile), which positions the provider as relatively strong in denosumab use compared with peers.

Billing intensity for office visits is an outlier: 99213 has 1.5K claims, $60 avg paid/claim, $88.7K revenue and ranks #2251 of 457151 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code). This unusually high volume of low‑level established patient visits indicates heavy follow‑up or visit frequency relative to national norms and likely reflects longitudinal management of oncology patients between infusions.

Ancillary diagnostic activity is high and clinic‑oriented: 85025 (CBC) shows 2.2K claims and $17.3K revenue, ranking #893 of 32833 providers nationally (97th percentile), and 36415 (venipuncture) shows 2.1K claims and $16.6K revenue, ranking #896 of 86467 providers nationally (99th percentile). These elevated percentiles for lab and phlebotomy codes are consistent with on‑site blood draws and laboratory monitoring that support an infusion oncology workflow.

Infusion and supportive care codes beyond the top drugs also stand out: J1439 (ferric carboxymaltose) has 87K claims, $87K revenue and ranks #87 of 1209 providers nationally (93rd percentile), and 96375 (sequential IV push infusion) has 831 claims, $9.1K revenue and ranks #237 of 5191 providers nationally (95th percentile; notably above typical national volume for this code). Presence of J2506 (pegfilgrastim) and other chemotherapy administration add‑ons reinforces a pattern of routine supportive oncology infusions alongside cytotoxic and targeted therapies.

From a payer‑mix and operational perspective, reliance on Medicare ($1.2M) with no Medicaid billing on file creates concentration exposure to Medicare reimbursement dynamics; business development or referral strategies tied to Medicaid populations would not be visible in these claims. For competitive benchmarking, the provider’s strength is programmatically in infusion‑centric oncology care rather than broad dominance on individual high‑cost oncology drugs at the national level.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

41 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	16,200	$40	$680.4K
J0897	Injection, denosumab, 1 mg	7,980	$20	$143.6K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,480	$60	$88.7K
J1439	Injection, ferric carboxymaltose, 1 mg	87,000	$1	$87K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	510	$90	$44.1K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	400	$90	$36.8K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	450	$50	$21.6K
85025	A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…	2,160	$10	$17.3K
36415	In this procedure, the provider inserts a needle into a vein to collect a blood sample.	2,070	$10	$16.6K
J9041	Injection, bortezomib, 0.1 mg	3,540	$1	$14.1K

Showing 1–10 of 41

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 41 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Mississippi Distribution

Laurie Douglas — 3 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Mississippi

Full comparison — all codes billed, vs. state median

41 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	7	10	16,700	$40	$1M
J0897	28	110	3,030	$20	$95.7K
J2506	9	10	910	$80	$91.5K
J1439	2	20	42,000	$1	$41.6K
96413	12	70	100	$80	$22.6K
99214	2,862	4,110	170	$70	$21.9K
J3490	6	20	90	$150	$17.8K
J9041	5	10	3,120	$1	$17.2K
99213	38	4,000	100	$50	$10.3K
G0498	12	10	60	$120	$8.4K

Showing 1–10 of 41

Related Providers

Other providers that share a Tax Identification Number (TIN) with Laurie Douglas, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Hattiesburg Clinic PA	MS	Multi-Specialty Clinic/Center	$0	$59.5M
Hattiesburg Clinic PA	MS	Pediatrics Physician	$0	$10.9M
Hattiesburg Clinic PA	MS	Pediatrics Physician	$0	$7.9M
State Of Mississippi - University Of Mississippi Medical Center	MS	Critical Access Hospital	$0	$7.5M
Hattiesburg Clinic PA	MS	Ambulatory Surgical Clinic/Center	$4.5M	$2.4M
Lowery A. Woodall Outpatient Surgery Facility, LLC	MS	Ambulatory Surgical Clinic/Center	$446.4K	$6.1M
Hattiesburg Clinic PA	MS	Clinical Medical Laboratory	$2.2M	$3.3M
Hattiesburg Clinic, PA	MS	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$5.3M
Imad Bitar	MS	Rheumatology Physician	$3M	$0
Hattiesburg Clinic PA	MS	Obstetrics & Gynecology Physician	$0	$2.8M

Nearby Providers

Other providers in the same ZIP code as Laurie Douglas, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Region 12 Commission On Mental Health & Retardation Pine Belt Men	MS	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$108.3M
Forrest County General Hospital	MS	General Acute Care Hospital	$0	$81.6M
Doves Home Care	MS	Home Health Agency	$0	$12M
Neighborhood Healthcare Providers	MS	Internal Medicine Physician	$0	$10.9M
Top Choice Healthcare	MS	In Home Supportive Care Agency	$0	$6M
Relias Emergency Medicine Specialists Of Hattiesburg LLC	MS	Emergency Medicine Physician	$0	$5M
Southern Surgery Center, LLC	MS	Ambulatory Surgical Clinic/Center	$4.7M	$103.6K
South Mississippi Emergency Physicians PA	MS	Emergency Medicine Physician	$0	$3.2M
Southern Mississippi Neonatology, PA	MS	Neonatal-Perinatal Medicine Physician	$0	$2.7M
Minor Care Clinic	MS	Federally Qualified Health Center (FQHC)	$0	$2.5M

Laurie Douglas — Billing Profile & Reimbursement Data

Sign up for Laurie Douglas — Billing Profile & Reimbursement Data policy alerts

Laurie Douglas — Billing Profile & Reimbursement Data

Sign up for Laurie Douglas — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References